Search

everythinglearnresearchcommunity

for

Search:↓

The new "whisker follicle microinjection assay" can test how different biomolecules affect hair growth and color.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Three cost-effective methods accurately measure finasteride in pharmaceuticals, better than current techniques.

Inhibiting SFRP1 may help treat hair loss.

The new "differential stripping" method effectively measures how much substance gets into hair follicles.

Fluorescence can effectively measure acne treatment progress.

The technique effectively shows how human skin and hair cells form into ball-like structures.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

The method reliably measures finasteride in human plasma.

Fibrosing alopecia can be diagnosed without typical signs of lichen planopilaris.

Cosmetic residues on individual hairs can be identified and differentiated using ATR FT-IR microspectroscopy.

Keratin film can effectively measure hair texture and adsorption properties.

A protein called sFRP4 from skin cells stops the development of pigment-producing cells in hair.

Fetal skin biopsy can help diagnose protein-related disorders before birth.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

Combining Nanofat with PRP is a safe and effective treatment for female pattern hair loss.

The fibroin-based formulation strengthens and repairs chemically damaged hair.

TrichoScan helps identify subtle hair thinning in women with androgenetic alopecia.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

New method measures finasteride in blood quickly and accurately.

The method effectively measures drug impact on DHT levels in prostate treatments.

SFRP2 and PTGDS may be key factors in female hair loss.

A hair test shows promise for early mood disorder diagnosis.

Method accurately measures finasteride in tablets using finasteride-BSA interaction.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

sFRP4 partially inhibits hair regeneration, but the study needs clearer data analysis and better explanation of the process.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

FFA and FAPD might be related or stages of the same disease.